In February 2020, SCIENION acquired the leasehold for the 3,037 m² state-owned property from urban development agent WISTA.Plan GmbH. The building permit has also been granted, and plans encompass the construction of a four-storied building complex with laboratories, clean rooms, production facilities, storerooms, areas for services, administration, sales and marketing as well as an underground car park. Construction is expected to be completed by the end of 2022.
Dr. Holger Eickhoff, CEO of SCIENION AG, states: “We are very pleased that we will be able to manage and bundle our global business activities from headquarters with sufficient space in the near future. And of course, we are glad that we are further expanding and SCIENION’s success story will continue to be written in the year of the company’s 20th anniversary.”
SCIENION offers complete solutions for precise liquid dispensing applications enabling high throughput production of multiparameter assays in diagnostics, and life and material sciences. Addressing the dynamically increasing needs for miniaturization and multiplex analyses, SCIENION offers a unique technology portfolio that has been continuously expanded for almost 20 years. SCIENION provides flexible solutions for research and development, wherein solutions for production purposes are customized. Systems and software are characterized by their versatility, precision and robustness. The company is a renowned specialist for ultra-low volume liquid handling, particularly for the handling of precious and sensitive compounds of biological or chemical origin. SCIENION’s dispensers allow for contact-free and precise drop spotting in the pico-liter to micro-liter range and are optimally suited for microarray based analytics – such as for tests with DNA, oligonucleotides, peptides, proteins, antibodies, glycans or for dispensing cells onto various substrates. The company operates from two sites in Germany, Dortmund and Berlin, and has subsidiaries in Phoenix, Arizona, USA, Lyon, France and Chichester, UK. Since August 2020, SCIENION is a CELLINK company. CELLINK is the leading bio-convergence company and a global provider of technologies, products and services to create, understand and master biology.
Scienion AG
Otto-Hahn-Straße 15
44227 Dortmund
Telefon: +49 (231) 9742-6900
Telefax: +49 (231) 9742-6901
https://www.scienion.com
Telefon: +49 (30) 6392-1700
Fax: +49 (30) 6392-1701
E-Mail: gebhard@scienion.com
